ELIZABETH MCMICKEN: Open Payments
NPI 1023538030 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 56 payments from 18 companies in 2025. Trend: 2023 $600 · 2024 $1,086 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| ABBVIE INC. | 9 | $138 |
| Dexcom, Inc. | 3 | $115 |
| Lilly USA, LLC | 6 | $106 |
| Novo Nordisk Inc | 5 | $102 |
| PFIZER INC. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Amgen Inc. | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
Products named: Dexcom G6 Transmitter, VRAYLAR, Ozempic, MOUNJARO, REXULTI, FARXIGA, AIRSUPRA, XIFAXAN.
Industry payments across SC — which companies pay providers there.
